Pace® Life Sciences Completes Successful EMA GMP Inspection at New Jersey Facility

Pace® Life Sciences Completes Successful EMA GMP Inspection at New Jersey Facility

Inspection outcome supports renewal of GMP certificate at Lebanon site providing pharmaceutical analytical testing and development support.

MINNEAPOLIS, MINNESOTA / October 28, 2026 / Pace® Life Sciences, a division of Pace®, a Science and Technology Company, has completed a European Medicines Agency (EMA) Good Manufacturing Practice (GMP) inspection at its Lebanon, New Jersey facility as part of its EU GMP certificate renewal process. Pace® Life Sciences is a U.S.-based, FDA-registered GMP analytical testing laboratory and full-service contract development and manufacturing organization (CDMO). Read Full Article.

Scroll to Top